HealthyWay Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,563	1,201	1,244	569.07	431.31
Revenue Growth (YoY)	30.13%	-3.51%	118.68%	31.94%	-
Cost of Revenue	1,086	834.86	846.22	323.27	257.83
Gross Profit	476.29	365.91	398.24	245.8	173.47
Selling, General & Admin	250.28	257.24	291.53	188.61	233.13
Research & Development	169.03	96.98	103.4	54.41	14.14
Other Operating Expenses	-5.07	-1.85	-4.06	-4.81	-4.51
Operating Expenses	414.24	352.37	390.87	238.21	242.77
Operating Income	62.05	13.54	7.36	7.59	-69.3
Interest Expense	-2.37	-4.48	-3.25	-1.58	-1.16
Interest & Investment Income	-	1.12	0.68	0.19	0.55
Earnings From Equity Investments	-0.37	-0.29	-0.07	0.89	-0.11
Currency Exchange Gain (Loss)	-	-0.93	-1.25	-4.84	1.46
Other Non Operating Income (Expenses)	-	-272.77	-324.78	-267.83	-84.37
EBT Excluding Unusual Items	59.32	-263.81	-321.31	-265.58	-152.93
Gain (Loss) on Sale of Investments	-	-	-	-	0.29
Gain (Loss) on Sale of Assets	-	0.01	0.36	7.98	0.56
Pretax Income	59.32	-263.8	-320.95	-257.61	-152.08
Income Tax Expense	4.98	5.36	-7.06	-1.97	3.22
Earnings From Continuing Operations	54.34	-269.16	-313.88	-255.64	-155.31
Minority Interest in Earnings	1.34	0.7	3.8	-2.49	-1.92
Net Income	55.68	-268.46	-310.08	-258.13	-157.22
Net Income to Common	55.68	-268.46	-310.08	-258.13	-157.22
Shares Outstanding (Basic)	878	715	700	-	-
Shares Outstanding (Diluted)	878	715	700	-	-
Shares Change (YoY)	22.66%	2.25%	-	-	-
EPS (Basic)	0.06	-0.38	-0.44	-	-
EPS (Diluted)	0.06	-0.38	-0.44	-	-
Free Cash Flow	74.98	55.77	2.4	8.49	13.76
Free Cash Flow Per Share	0.09	0.08	0.00	-	-
Gross Margin	30.48%	30.47%	32.00%	43.19%	40.22%
Operating Margin	3.97%	1.13%	0.59%	1.33%	-16.07%
Profit Margin	3.56%	-22.36%	-24.92%	-45.36%	-36.45%
Free Cash Flow Margin	4.80%	4.64%	0.19%	1.49%	3.19%
EBITDA	93.85	45.34	22.27	8.22	-67.65
EBITDA Margin	6.01%	3.78%	1.79%	1.44%	-15.68%
D&A For EBITDA	31.8	31.8	14.91	0.64	1.65
EBIT	62.05	13.54	7.36	7.59	-69.3
EBIT Margin	3.97%	1.13%	0.59%	1.33%	-16.07%
Effective Tax Rate	8.39%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.